News | May 26, 2025
Divi's Laboratories inks manufacturing and supply agreement with global pharma company
The company expects meaningful revenue contribution from this long-term agreement
The company expects meaningful revenue contribution from this long-term agreement
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
Anti-malaria API facility will be operational in 15-18 months
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Subscribe To Our Newsletter & Stay Updated
